JP2009506029A5 - - Google Patents

Download PDF

Info

Publication number
JP2009506029A5
JP2009506029A5 JP2008527875A JP2008527875A JP2009506029A5 JP 2009506029 A5 JP2009506029 A5 JP 2009506029A5 JP 2008527875 A JP2008527875 A JP 2008527875A JP 2008527875 A JP2008527875 A JP 2008527875A JP 2009506029 A5 JP2009506029 A5 JP 2009506029A5
Authority
JP
Japan
Prior art keywords
active ingredient
chlorobenzyl
piperidin
hydroxyphenyl
oxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2008527875A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009506029A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/SE2006/000971 external-priority patent/WO2007024183A1/en
Publication of JP2009506029A publication Critical patent/JP2009506029A/ja
Publication of JP2009506029A5 publication Critical patent/JP2009506029A5/ja
Pending legal-status Critical Current

Links

JP2008527875A 2005-08-26 2006-08-24 呼吸器疾患、特に慢性閉塞性肺疾患（ｃｏｐｄ）および喘息の処置に使用し得る化合物の組み合わせ Pending JP2009506029A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0501895 2005-08-26
SE0601221 2006-06-01
PCT/SE2006/000971 WO2007024183A1 (en) 2005-08-26 2006-08-24 A combination of compounds, which can be used in the treatment of respiratory diseases, especially chronic obstructive pulmonary disease (copd) and asthma

Publications (2)

Publication Number Publication Date
JP2009506029A JP2009506029A (ja) 2009-02-12
JP2009506029A5 true JP2009506029A5 (https=) 2009-10-08

Family

ID=37771857

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008527875A Pending JP2009506029A (ja) 2005-08-26 2006-08-24 呼吸器疾患、特に慢性閉塞性肺疾患（ｃｏｐｄ）および喘息の処置に使用し得る化合物の組み合わせ

Country Status (12)

Country Link
US (1) US20090298875A1 (https=)
EP (1) EP1922070A1 (https=)
JP (1) JP2009506029A (https=)
KR (1) KR20080038178A (https=)
AU (1) AU2006282122A1 (https=)
BR (1) BRPI0615064A2 (https=)
CA (1) CA2620281A1 (https=)
IL (1) IL189182A0 (https=)
MX (1) MX2008002320A (https=)
NO (1) NO20081483L (https=)
RU (1) RU2008108176A (https=)
WO (1) WO2007024183A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR028948A1 (es) 2000-06-20 2003-05-28 Astrazeneca Ab Compuestos novedosos
TW200738634A (en) * 2005-08-02 2007-10-16 Astrazeneca Ab New salt
WO2008103126A1 (en) * 2007-02-23 2008-08-28 Astrazeneca Ab Novel combination of compounds to be used in the treatment of airway diseases, especially chronic obstructive pulmonary disease (copd) and asthma
US20110136843A1 (en) * 2007-02-23 2011-06-09 Tomas Eriksson Novel Combination of Compounds to be Used in the Treatment of Airway Diseases, Especially Chronic Obstructive Pulmonary Disease (COPD) and Asthma
WO2009074666A1 (en) * 2007-12-13 2009-06-18 Novartis Ag Organic compounds

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3994974A (en) * 1972-02-05 1976-11-30 Yamanouchi Pharmaceutical Co., Ltd. α-Aminomethylbenzyl alcohol derivatives
GB8334494D0 (en) * 1983-12-24 1984-02-01 Tanabe Seiyaku Co Carbostyril derivatives
GB9913083D0 (en) * 1999-06-04 1999-08-04 Novartis Ag Organic compounds
EP1294690A2 (en) * 2000-06-21 2003-03-26 Bristol-Myers Squibb Pharma Company N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
JP4143413B2 (ja) * 2001-03-22 2008-09-03 グラクソ グループ リミテッド β２−アドレナリン受容体アゴニストとしてのホルムアニリド誘導体
SE0104251D0 (sv) * 2001-12-14 2001-12-14 Astrazeneca Ab Novel compounds
GB0207436D0 (en) * 2002-03-28 2002-05-08 Glaxo Group Ltd Novel compounds
US20060183731A1 (en) * 2003-07-15 2006-08-17 Min Ge 7 and 8 membered heterocyclic cyclopentyl benzylamide modulators of chemokine receptor activity

Similar Documents

Publication Publication Date Title
ES2309503T3 (es) Medicamento que comprende un agonista beta 2 de larga duracion, muy potente, en combinacion con otros ingredientes activos.
RU2019100425A (ru) Новая доза и препаративная форма
JP2505944B2 (ja) （Ｓ）―α―フルオロメチル―ヒスチジン及びそのエステルを含有するぜん息治療用医薬組成物
ES2739352T3 (es) Formulaciones farmacéuticas que comprenden 4-{(1R)-2-[(6-{2-[(2,6-diclorobencil)oxi]etoxi}hexil)amino]-1-hidroxietil}-2-(hidroximetil)fenol
JP2018199684A5 (https=)
ATE330589T1 (de) Pharmazeutische zusammensetzung enthaltend resveratrol zur behandlung von entzündlichen erkrankungen der atemwege
RU2004122921A (ru) Композиция для ингаляции
RU2018115685A (ru) Фармацевтическая композиция
BG65189B1 (bg) Фармацевтичен състав на база антихолинергично активно съединение и бета-миметик
CA2550841A1 (en) Novel combination of anticholinergic and .beta. mimetics for the treatment of respiratory diseases
EA023839B1 (ru) Комбинации антагониста мускариновых рецепторов и агониста бета-2-адренорецепторов
JP6234899B2 (ja) 喘息及びアレルギー性鼻炎の治療におけるアルギナーゼ阻害剤の使用
JP2012505262A (ja) Ｃｏｐｄ及びその他の肺疾患の治療方法
TWI905086B (zh) 包含雷芬那新（ｒｅｖｅｆｅｎａｃｉｎ）之醫藥組合物用於治療慢性阻塞性肺疾病之用途及選擇治療用之吸入遞送裝置之方法
JP5492072B2 (ja) 喘息の増悪の予防および／または治療のためのフォルモテロールおよびジプロピオン酸ベクロメタゾンを含む組成物の使用
BR112020015646A2 (pt) Formulações intranasais de epinefrina e métodos para o tratamento de doença
RU2008124825A (ru) Органические соединения, включающие соль гликопиррония
RU2008108175A (ru) Комбинация соединений, которые можно использовать при лечении респираторных заболеваний, особенно хронической оструктивной болезни легких (copo) и астмы
JP2005514440A (ja) アミドおよび／またはエステルを含有する、賦形剤化合物を含む、医用エアロゾル組成物
JP2009506029A5 (https=)
RU2010120806A (ru) Композиции для ингаляции, содержащие кислоту монтелукаст и ингибитор pde-4 или ингаляционный кортикостероид
EA200600886A1 (ru) Способ получения солей тиотропия, соли тиотропия, а также содержащие их лекарственные композиции
JP2008115167A (ja) トラネキサム酸を含有する気道杯細胞過形成抑制剤
TWI253930B (en) Novel combination of loteprednol and beta2 adrenoceptor agonists
JP2011500731A5 (https=)